InvestorsHub Logo
Followers 138
Posts 23165
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Thursday, 03/02/2023 12:09:01 AM

Thursday, March 02, 2023 12:09:01 AM

Post# of 462563
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167374/

Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News